No images? Click here

IDCRC Banner with logo

IDCRC Newsletter: August 2025

IDCRC Administration Team Transition

Jacquelyn Manduley, MBA, named new administrative director for the Leadership Group

We are pleased to announce that Jacquelyn Manduley, MBA, will be transitioning into the role of administrative director for the IDCRC Leadership Group (LG). 

Jacquelyn has worked with the IDCRC’s administrative team for two years and with Emory University, managing research administration for seven years. In her new role, Jacquelyn will lead the LOC Administrative Core in continuing to provide administrative, financial, communications, and managerial support for the LG.  She will have significant oversight of the day-to-day management of the IDCRC components and activities, and will work in close coordination with the PIs, unit leaders, and our DMID partners to ensure our network is running efficiently and effectively. Please join us in congratulating Jacquelyn on her new role!

 

Jodi Salim, MPH, joins Emory School of Medicine's Division of Infectious Diseases

Jodi Salim, MPH, served as the administrative director from September 2022 to July 2025. Her impact on the network has been immense, with her exemplary leadership of our admin team and her outstanding partnership with our researchers. In recognition of her contributions to the network, she was named the 2024 recipient of the IDCRC Annual Leadership Group Award.

 

Jodi has stepped into the role of administrator for the Division of Infectious Diseases with Emory's School of Medicine as of August 1, 2025. She will continue to work with the IDCRC network on a part-time basis during the transition period. Please join us in congratulating Jodi and expressing our thanks for her outstanding service to the IDCRC.

 

Igho Ofotokun Embarks on a New Journey

Igho Ofotokun, MD, MSc (Emory), has stepped down as co-chair of the Mentoring, Career Development and Training Committee (MCDC) to pursue an exciting new opportunity as the Chair of Medicine at University Hospitals/Case Western in Cleveland, Ohio. As he departs for this new opportunity, the IDCRC is thrilled to welcome Zanthia Wiley, MD (Emory), into this role, as of August 1, 2025.

Dr. Wiley shares the following about her former mentor. “Having Dr. O as my primary mentor over the past five years has been a MasterClass in mentorship. He challenged and motivated me to be my best. He held me accountable, served as a sounding board, provided constructive feedback, and shared opportunities, advice, and experiences that have helped me attain many of my career dreams. I am incredibly fortunate to have had the opportunity to be guided by him and will aim to instill many of the lessons that I learned from him into my own mentees.”

Dr. Ofotokun reflects on his time with the IDCRC, sharing the following sentiments. "I have been actively involved with the IDCRC since its inception. I felt tremendously honored when the leadership entrusted me with the responsibility of developing the MCDC with Kathy Edwards, MD (Vanderbilt). Being part of the foundational stages of this program has been both inspiring and rewarding, as it represents a significant effort to foster the growth and development of future leaders in infectious diseases research."

Before Dr. Ofotkun officially embarks on his next endeavor, we would like to spotlight his impactful contributions and transformative leadership over the years. Read the spotlight below to hear insights from his colleagues about his significant contributions to the network, along with a profile highlighting key moments from his time with the IDCRC.

READ OFOTOKUN'S SPOTLIGHT HERE
 

IDCRC Investigator Profile: Ralf Duerr, MD, PhD

Headshot of Ralf Duerr, MD, PhD
READ DUERR'S FULL SPOTLIGHT

Ralf Duerr, MD, PhD, is a research associate professor in the Department of Medicine within the NYU Grossman School of Medicine. His research focuses on the functional and genomic dimensions of viral infections, including but not limited to SARS-CoV-2, HIV-1, mpox, and influenza.

"As the name Infectious Diseases Clinical Research Consortium (IDCRC) suggests, one of its key strengths is its extensive network of experts in clinical trials and research, both nationally and internationally. This extensive knowledge base, combined with the power to effect change in patient treatment, is what makes the consortium so impactful. For me, this patient-centered focus is essential in making clinical studies truly worthwhile, and the IDCRC exemplifies this priority," shares Duerr.

 

Annual Meeting

Save the Date! 2026 Annual Meeting

Mark your calendars! Next year's IDCRC Annual Meeting will take place on Wednesday, May 13, and Thursday, May 14, 2026. We look forward to seeing everyone then. Stay tuned for more details in early 2026!

If you didn't get to join us in May for the meeting, be sure to check out the 2025 recap story. Read for a sneak peek into what to expect at the event, including our annual awards program, presentations, breakout groups, and much more!

2025 ANNUAL MEETING RECAP
 

Training

IDCRC Mentee Profile: Danielle Fayad, MD

Danielle Fayad, MD, is a pediatric infectious diseases fellow at Cincinnati Children’s Hospital Medical Center and is currently pursuing a Master of Science in Epidemiology at the London School of Hygiene and Tropical Medicine. Her research focuses on maternal immunization and antibody transfer to infants, aiming to help protect vulnerable newborns from infectious diseases. She is especially interested in understanding factors that affect maternal-infant immunity.

Dr. Fayad is a member of the IDCRC's Mentorship Program cohort. She shares what she looks forward to as a member of the IDCRC's Mentorship Program, below.

Danielle Fayad, MD headshot

"I am looking forward to building leadership skills and forging meaningful connections with like-minded colleagues and mentors within the IDCRC community. I am also excited about opportunities to network, gain exposure to different aspects of infectious disease research, and learn from experts in the field."

READ FAYAD'S PROFILE HERE
 

MCDC Mentoring Lecture Series

The IDCRC Mentoring Lecture Series brings the IDCRC mentees together with leading experts to discuss topics related to the VTEUs, vaccinology, and clinical trials development and management. Check out our recent lecture below!

 
Meet the journaling community  Skip navigation Search    Create  9+  Avatar image IDCRC MCDC August Lecture Series

Scientific Communication

Presenter:
Preeti Malani, MD, MSJ
Professor of Medicine,
University of Michigan
Deputy Director, JAMA

VIEW FULL ARCHIVE
 

News

National Foundation for Infectious Diseases (NFID) Announces 2025-2026 Board of Directors

Congratulations to the following individuals on their recent appointment to the NFID Board of Directors. The individuals will serve three-year terms through June 2028. As the governing body of NFID, the Board of Directors establishes the organization's strategic direction, ensures that annual goals are met, and provides financial oversight.

IDCRC VTEU Investigators:

  • Wilbur H. Chen, MD, MS, University of Maryland School of Medicine 
  • Flor M. Muñoz, MD, MSc, Baylor College of Medicine

Former IDCRC Leadership Group Members:

  • Monica M. Farley, MD (NFID President-Elect), Emory University School of Medicine 
  • Kathleen M. Neuzil, MD, MPH, Federal Liaison 
READ FULL PRESS RELEASE
 

WKRN: Kids & Vaccines Town Hall

C. Buddy Creech, MD, MPH, FPIDS, professor of Pediatric Infectious Diseases and the director of the Vanderbilt Vaccine Research Program, participated in a town hall on kids and vaccines hosted by WKR-TV, the ABC affiliate in Nashville.

WKRN: Kids & Vaccines Town Hall
WATCH KIDS & VACCINES TOWN HALL
 

American Society of Transplantation announces new leadership

Congratulations to MCDC co-chair, Lara Danziger-Isakov⁠, MD, on being elected to the American Society of Transplantation (ATS) Board of Directors as a Councilor-at-Large. She will serve a three-year term through 2028.

About ATS:
ATS is the largest transplant organization in North America and is recognized as the premier society for transplant professionals. They currently have over 5,000 members dedicated to advancing the field of transplantation and improving patient care by promoting research, education, advocacy, and organ donation. 

READ MORE ON ATS BOARD OF DIRECTORS
 

Share your news! Help us shine a spotlight on YOU!

We are thankful for our incredible expansive network of investigators, staff, and administrative team members! Help us shine a spotlight on YOU!

Not sure what to submit? Below are a few ideas...

Clip art of hand holding microphone
  • Have you or a team member received an award recently?
  • Do you know an investigator who was recently featured in the media?
  • Do you know someone who is doing excellent work and deserves a shoutout to the network?
  • Do you want to promote an event, a job opening on your team, a research opportunity at your institution?
  • Are you in a professional development program? Did you run a marathon? Get married? Complete a personal accomplishment?

If you answered YES to any of the questions above, or have another idea in mind for a future IDCRC newsletter, contact our team!

SEND US YOUR NEWS HERE
 

Job Postings

Newly Posted! Infectious Diseases Research Job Openings

  • Molecular Microbiology Laboratory at Mount Sinai Hospital - Postdoctoral Fellow/Infectious Diseases Translational Research 

  • NYU Langone Health - Faculty Opportunity: Infectious Diseases Clinician Educator   

  • Oregon Health & Science University - Infectious Disease MD/DO - Assistant Professor  

  • University of Georgia - Infectious Disease Forecasting Postdoctoral Position 

  • The University of Texas at Austin - Senior Administrative Program Coordinator, Division of Infectious Disease 

Visit the IDSA Career Center to browse other ID/HIV Medicine job postings.

 

Funding Opportunities

2026 Deadline: 

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)  
Deadline: Thursday, October 16, 2025 

Notice of Special Interest (NOSI): Complement in Fundamental Immunology 
Deadline:  Tuesday, January 7, 2026

Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine 
Deadline: Thursday, January 15, 2026

Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
Deadline: Friday, July 17, 2026

Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses  
Deadline: Friday, July 17, 2026

2027 Deadline:

Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV) 
Deadline: Wednesday, April 6, 2027

Notice of Special Interest (NOSI): Systems Modeling of Infection and Immunity Across Biological Scales 
Deadline: Wednesday, September 8, 2027

Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine 
Deadline: Sunday, November 17, 2027

Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery 
Deadline: Sunday, November 17, 2027

 

IDCRC Studies

Active Studies
Recruiting Volunteers

  • A Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of Sanaria(R) PfSPZ-LARC2 Vaccine, a Late-Arresting, Replication-Competent, Genetically Attenuated Plasmodium Falciparum Vaccine by Controlled Human Malaria Infection in Malaria-Naïve Healthy Adults
    Conditions (DMID 23-0010)
     
  • Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults (DMID 23-0006)
     
  • A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection (DMID 22-0019)

Fully Enrolled Studies
in Follow-up

  • A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001B WNV in Healthy Adults (DMID 24-0008)
     

  • Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine (DMID 22-0020A)
     

  • A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety and Pharmacokinetics of a Single Ascending Dose of EV-D68-228 in Healthy Adult Volunteers (DMID 23-0005)
     
  • A Prospective, Randomized, Open-label Phase 4 Study of the Immunology and Safety of Maternal RSV Vaccination (ABRYSVOTM), Infant Nirsevimab (BEYFORTUSTM) Immunization, or Both Products During the First Year of Life (PROMISE) (DMID 24-0003)
IDCRC ACTIVE AND COMPLETED STUDIES
 

IDCRC Concept Quick Stats

ICP Status

  • Approved: 64

  • Administratively Not Supported: 29

  • Not Approved: 60

  • EWG Review: 25

  • EWG Liaisons: 0

  • EMT Concurrence: 0

  • Withdrawn: 23

  • Hold: 2

  • Moved to Active Study: 7

EWG Assignment

  • COVID: 92

  • Respiratory: 50

  • Emerging Infections: 22

  • Enteric Inf.: 12

  • Malaria and Tropical Dis.: 13

  • Sexually Transmitted Infections: 19

  • Mpox: 7

ECP Status

  • EWG Review-In Process: 0

  • EMT Review: 1

  • Approved-moved to Prioritization: 2

  • Not Approved: 29

  • Approved-moved to Protocol development: 1

  • Active Study: 7

  • EMT Vote: 0

  • Study in Protocol Development: 4

  • Study Closed (LSLV Complete): 9

  • Other: 11

IDCRC STUDIES
 

Communication Resources

COMMUNICATION TOOLKIT
 

Please submit IDCRC news to idcrc@emory.edu for inclusion in the monthly newsletter and IDCRC.org.

VISIT IDCRC WEBSITE
NEWSLETTER ARCHIVE
SUBSCRIBE TO NEWSLETTER
 
 
 

Woodruff Health Sciences Center
Emory University
1440 Clifton Road NE
Atlanta, GA 30322, United States

Subscribe

Preferences  |  Unsubscribe